Rare Biomarkers Specimen Collection And Stabilization Market by Type and Application - Global Industry Analysis & Forecast to 2027
Published On : August 2020 Pages : 160 Category: Biotechnology Report Code : HC0812554
Rare Biomarkers Specimen Collection And Stabilization Market by Type (Circulating Cell Free DNA (ccfDNA), Circulating Tumor Cells (CTCs), Exosomes/Extracellular Vesicles, Circulating Cell Free RNA (ccfRNA) / miRNA) Application (Research, Diagnostics) - Global Industry Analysis & Forecast to 2027
Industry Outlook and Trend Analysis
The Rare Biomarkers Specimen Collection And Stabilization Market has encountered significant development over the recent years and is anticipated to grow tremendously over the forecast period. Rare Biomarkers Specimen Collection And Stabilization is helping medical research by shedding light on the physiopathological mechanisms of disease.
Drivers and Restraints
Top-down and bottom-up approaches are used to validate the global market and estimate the market size for company, regions segments, type segments and applications (end users). In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Regional Insights
The data for 2021 is an estimate, based on the history data and the integrated view of industry experts, manufacturers, distributors and end users etc.
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Southeast Asia
- Rest of Asia-Pacific
- South America
- Brazil
- Argentina
- Columbia
- Rest of South America
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Nigeria
- South Africa
- Rest of MEA
Competitive Analysis
The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.
- Agena Bioscience
- ANGLE plc
- AS ONE INTERNATIONAL
- BioChain Institute, Inc.
- Biolidics Limited
- Biomatrica
- Bio-Techne Corporation
- BioVision, Inc.
- Caltag Medsystems Limited
- OraSure Technologies Inc.
Some of the key questions answered by the report are:
- What was the market size in 2017 and forecast from 2021 to 2027?
- What will be the industry market growth from 2017 to 2027?
- What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
- What are the major segments leading the market growth and why?
- Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?
Market Classification
· Rare Biomarkers Specimen Collection And Stabilization Market, By Type, Estimates and Forecast, 2017-2027 ($Million)
o Circulating Cell Free DNA (ccfDNA)
o Circulating Tumor Cells (CTCs)
o Exosomes/Extracellular Vesicles
o Circulating Cell Free RNA (ccfRNA) / miRNA
· Rare Biomarkers Specimen Collection And Stabilization Market, By Application, Estimates and Forecast, 2017-2027 ($Million)
o Research
o Diagnostics
· Rare Biomarkers Specimen Collection And Stabilization Market, By Key Players, Estimates and Forecast, 2017-2027 ($Million)
o Agena Bioscience
o ANGLE plc
o AS ONE INTERNATIONAL
o BioChain Institute, Inc.
o Biolidics Limited
o Biomatrica
o Bio-Techne Corporation
o BioVision, Inc.
o Caltag Medsystems Limited
o OraSure Technologies Inc.
· Rare Biomarkers Specimen Collection And Stabilization Market, By Region, Estimates and Forecast, 2017-2027 ($Million)
o North America
§ North America Rare Biomarkers Specimen Collection And Stabilization Market, By Country
o U.S. Rare Biomarkers Specimen Collection And Stabilization Market
o Canada Rare Biomarkers Specimen Collection And Stabilization Market
o Mexico Rare Biomarkers Specimen Collection And Stabilization Market
o Europe
§ Europe Rare Biomarkers Specimen Collection And Stabilization Market, By Country
o Germany Rare Biomarkers Specimen Collection And Stabilization Market
o UK Rare Biomarkers Specimen Collection And Stabilization Market
o France Rare Biomarkers Specimen Collection And Stabilization Market
o Russia Rare Biomarkers Specimen Collection And Stabilization Market
o Italy Rare Biomarkers Specimen Collection And Stabilization Market
o Rest of Europe Rare Biomarkers Specimen Collection And Stabilization Market
o Asia-Pacific
§ Asia-Pacific Rare Biomarkers Specimen Collection And Stabilization Market, By Country
o China Rare Biomarkers Specimen Collection And Stabilization Market
o Japan Rare Biomarkers Specimen Collection And Stabilization Market
o South Korea Rare Biomarkers Specimen Collection And Stabilization Market
o India Rare Biomarkers Specimen Collection And Stabilization Market
o Southeast Asia Rare Biomarkers Specimen Collection And Stabilization Market
o Rest of Asia-Pacific Rare Biomarkers Specimen Collection And Stabilization Market
o South America
§ South America Rare Biomarkers Specimen Collection And Stabilization Market, By Country
o Brazil Rare Biomarkers Specimen Collection And Stabilization Market
o Argentina Rare Biomarkers Specimen Collection And Stabilization Market
o Columbia Rare Biomarkers Specimen Collection And Stabilization Market
o Rest of South America Rare Biomarkers Specimen Collection And Stabilization Market
o Middle East and Africa
§ Middle East and Africa Rare Biomarkers Specimen Collection And Stabilization Market, By Country
o Saudi Arabia Rare Biomarkers Specimen Collection And Stabilization Market
o UAE Rare Biomarkers Specimen Collection And Stabilization Market
o Egypt Rare Biomarkers Specimen Collection And Stabilization Market
o Nigeria Rare Biomarkers Specimen Collection And Stabilization Market
o South Africa Rare Biomarkers Specimen Collection And Stabilization Market
o Rest of MEA Rare Biomarkers Specimen Collection And Stabilization Market
Table of Contents:
1. Introduction
1.1. Report Description
2. Executive Summary
2.1. Key Highlights
3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
4. Market Analysis by Regions
4.1. North America (United States, Canada and Mexico)
4.1.1. United States Market Status and Outlook (2017-2027)
4.1.2. Canada Market Status and Outlook (2017-2027)
4.1.3. Mexico Market Status and Outlook (2017-2027)
4.2. Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
4.2.1. Germany Market Status and Outlook (2017-2027)
4.2.2. France Market Status and Outlook (2017-2027)
4.2.3. UK Market Status and Outlook (2017-2027)
4.2.4. Russia Market Status and Outlook (2017-2027)
4.2.5. Italy Market Status and Outlook (2017-2027)
4.2.6. Rest of Europe Market Status and Outlook (2017-2027)
4.3. Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)
4.3.1. China Market Status and Outlook (2017-2027)
4.3.2. Japan Market Status and Outlook (2017-2027)
4.3.3. Korea Market Status and Outlook (2017-2027)
4.3.4. India Market Status and Outlook (2017-2027)
4.3.5. Southeast Asia Market Status and Outlook (2017-2027)
4.3.6. Rest of Asia-Pacific Market Status and Outlook (2017-2027)
4.4. South America (Brazil, Argentina, Columbia and Rest of South America)
4.4.1. Brazil Market Status and Outlook (2017-2027)
4.4.2. Argentina Market Status and Outlook (2017-2027)
4.4.3. Columbia Market Status and Outlook (2017-2027)
4.4.4. Rest of South America Market Status and Outlook (2017-2027)
4.5. Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)
4.5.1. Saudi Arabia Market Status and Outlook (2017-2027)
4.5.2. United Arab Emirates Market Status and Outlook (2017-2027)
4.5.3. Egypt Market Status and Outlook (2017-2027)
4.5.4. Nigeria Market Status and Outlook (2017-2027)
4.5.5. South Africa Market Status and Outlook (2017-2027)
4.5.6. Turkey Market Status and Outlook (2017-2027)
4.5.7. Rest of Middle East and Africa Market Status and Outlook (2017-2027)
5. Rare Biomarkers Specimen Collection And Stabilization Market, By Type
5.1. Introduction
5.2. Global Rare Biomarkers Specimen Collection And Stabilization Revenue and Market Share by Type (2017-2021)
5.2.1. Global Rare Biomarkers Specimen Collection And Stabilization Revenue and Revenue Share by Type (2017-2021)
5.3. Circulating Cell Free DNA (ccfDNA)
5.3.1. Global Circulating Cell Free DNA (ccfDNA) Revenue and Growth Rate (2017-2021)
5.4. Circulating Tumor Cells (CTCs)
5.4.1. Global Circulating Tumor Cells (CTCs) Revenue and Growth Rate (2017-2021)
5.5. Exosomes/Extracellular Vesicles
5.5.1. Global Exosomes/Extracellular Vesicles Revenue and Growth Rate (2017-2021)
5.6. Circulating Cell Free RNA (ccfRNA) / miRNA
5.6.1. Global Circulating Cell Free RNA (ccfRNA) / miRNA Revenue and Growth Rate (2017-2021)
6. Rare Biomarkers Specimen Collection And Stabilization Market, By Applications
6.1. Introduction
6.2. Global Rare Biomarkers Specimen Collection And Stabilization Revenue and Market Share by Applications (2017-2021)
6.2.1. Global Rare Biomarkers Specimen Collection And Stabilization Revenue and Revenue Share by Applications (2017-2021)
6.3. Research
6.3.1. Global Research Revenue and Growth Rate (2017-2021)
6.4. Diagnostics
6.4.1. Global Diagnostics Revenue and Growth Rate (2017-2021)
7. Rare Biomarkers Specimen Collection And Stabilization Market, By Region
7.1. Introduction
7.2. Global Rare Biomarkers Specimen Collection And Stabilization Revenue and Market Share by Regions
7.2.1. Global Rare Biomarkers Specimen Collection And Stabilization Revenue by Regions (2017-2021)
7.3. North America Rare Biomarkers Specimen Collection And Stabilization by Countries
7.3.1. North America Rare Biomarkers Specimen Collection And Stabilization Revenue and Growth Rate (2017-2021)
7.3.2. North America Rare Biomarkers Specimen Collection And Stabilization Revenue (Million USD) by Countries (2017-2021)
7.3.3. United States
7.3.3.1. United States Rare Biomarkers Specimen Collection And Stabilization Revenue (Millions USD) and Growth Rate (2017-2021)
7.3.4. Canada
7.3.4.1. Canada Rare Biomarkers Specimen Collection And Stabilization Revenue (Millions USD) and Growth Rate (2017-2021)
7.3.5. Mexico
7.3.5.1. Mexico Rare Biomarkers Specimen Collection And Stabilization Revenue (Millions USD) and Growth Rate (2017-2021)
7.4. Europe Rare Biomarkers Specimen Collection And Stabilization by Countries
7.4.1. Europe Rare Biomarkers Specimen Collection And Stabilization Revenue and Growth Rate (2017-2021)
7.4.2. Europe Rare Biomarkers Specimen Collection And Stabilization Revenue (Million USD) by Countries (2017-2021)
7.4.3. Germany
7.4.3.1. Germany Rare Biomarkers Specimen Collection And Stabilization Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.4. France
7.4.4.1. France Rare Biomarkers Specimen Collection And Stabilization Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.5. UK
7.4.5.1. UK Rare Biomarkers Specimen Collection And Stabilization Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.6. Russia
7.4.6.1. Russia Rare Biomarkers Specimen Collection And Stabilization Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.7. Italy
7.4.7.1. Italy Rare Biomarkers Specimen Collection And Stabilization Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.8. Rest of Europe
7.4.8.1. Rest of Europe Rare Biomarkers Specimen Collection And Stabilization Revenue (Millions USD) and Growth Rate (2017-2021)
7.5. Asia-Pacific Rare Biomarkers Specimen Collection And Stabilization by Countries
7.5.1. Asia-Pacific Rare Biomarkers Specimen Collection And Stabilization Revenue and Growth Rate (2017-2021)
7.5.2. Asia-Pacific Rare Biomarkers Specimen Collection And Stabilization Revenue (Million USD) by Countries (2017-2021)
7.5.3. China
7.5.3.1. China Rare Biomarkers Specimen Collection And Stabilization Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.4. Japan
7.5.4.1. Japan Rare Biomarkers Specimen Collection And Stabilization Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.5. Korea
7.5.5.1. Korea Rare Biomarkers Specimen Collection And Stabilization Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.6. India
7.5.6.1. India Rare Biomarkers Specimen Collection And Stabilization Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.7. Southeast Asia
7.5.7.1. Southeast Asia Rare Biomarkers Specimen Collection And Stabilization Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.8. Rest of Asia-Pacific
7.5.8.1. Rest of Asia-Pacific Rare Biomarkers Specimen Collection And Stabilization Revenue (Millions USD) and Growth Rate (2017-2021)
7.6. South America Rare Biomarkers Specimen Collection And Stabilization by Countries
7.6.1. South America Rare Biomarkers Specimen Collection And Stabilization Revenue and Growth Rate (2017-2021)
7.6.2. South America Rare Biomarkers Specimen Collection And Stabilization Revenue (Million USD) by Countries (2017-2021)
7.6.3. Brazil
7.6.3.1. Brazil Rare Biomarkers Specimen Collection And Stabilization Revenue (Millions USD) and Growth Rate (2017-2021)
7.6.4. Argentina
7.6.4.1. Argentina Rare Biomarkers Specimen Collection And Stabilization Revenue (Millions USD) and Growth Rate (2017-2021)
7.6.5. Columbia
7.6.5.1. Columbia Rare Biomarkers Specimen Collection And Stabilization Revenue (Millions USD) and Growth Rate (2017-2021)
7.6.6. Rest of South America
7.6.6.1. Rest of South America Rare Biomarkers Specimen Collection And Stabilization Revenue (Millions USD) and Growth Rate (2017-2021)
7.7. Middle East and Africa Rare Biomarkers Specimen Collection And Stabilization by Countries
7.7.1. Middle East and Africa Rare Biomarkers Specimen Collection And Stabilization Revenue and Growth Rate (2017-2021)
7.7.2. Middle East and Africa Rare Biomarkers Specimen Collection And Stabilization Revenue (Million USD) by Countries (2017-2021)
7.7.3. Saudi Arabia
7.7.3.1. Saudi Arabia Rare Biomarkers Specimen Collection And Stabilization Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.4. United Arab Emirates
7.7.4.1. United Arab Emirates Rare Biomarkers Specimen Collection And Stabilization Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.5. Egypt
7.7.5.1. Egypt Rare Biomarkers Specimen Collection And Stabilization Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.6. Nigeria
7.7.6.1. Nigeria Rare Biomarkers Specimen Collection And Stabilization Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.7. South Africa
7.7.7.1. South Africa Rare Biomarkers Specimen Collection And Stabilization Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.8. Turkey
7.7.8.1. Turkey Rare Biomarkers Specimen Collection And Stabilization Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.9. Rest of Middle East and Africa
7.7.9.1. Rest of Middle East and Africa Rare Biomarkers Specimen Collection And Stabilization Revenue (Millions USD) and Growth Rate (2017-2021)
8. Company Profiles
8.1. Agena Bioscience
8.1.1. Business Overview
8.1.2. Service Portfolio
8.1.3. Strategic Developments
8.1.4. Financial Overview
8.2. ANGLE plc
8.2.1. Business Overview
8.2.2. Service Portfolio
8.2.3. Strategic Developments
8.2.4. Financial Overview
8.3. AS ONE INTERNATIONAL
8.3.1. Business Overview
8.3.2. Service Portfolio
8.3.3. Strategic Developments
8.3.4. Financial Overview
8.4. BioChain Institute, Inc.
8.4.1. Business Overview
8.4.2. Service Portfolio
8.4.3. Strategic Developments
8.4.4. Financial Overview
8.5. Biolidics Limited
8.5.1. Business Overview
8.5.2. Service Portfolio
8.5.3. Strategic Developments
8.5.4. Financial Overview
8.6. Biomatrica
8.6.1. Business Overview
8.6.2. Service Portfolio
8.6.3. Strategic Developments
8.6.4. Financial Overview
8.7. Bio-Techne Corporation
8.7.1. Business Overview
8.7.2. Service Portfolio
8.7.3. Strategic Developments
8.7.4. Financial Overview
8.8. BioVision, Inc.
8.8.1. Business Overview
8.8.2. Service Portfolio
8.8.3. Strategic Developments
8.8.4. Financial Overview
8.9. Caltag Medsystems Limited
8.9.1. Business Overview
8.9.2. Service Portfolio
8.9.3. Strategic Developments
8.9.4. Financial Overview
8.10. OraSure Technologies Inc.
8.10.1. Business Overview
8.10.2. Service Portfolio
8.10.3. Strategic Developments
8.10.4. Financial Overview
9. Rare Biomarkers Specimen Collection And Stabilization Market Forecast (2022-2027)
9.1. Global Rare Biomarkers Specimen Collection And Stabilization Revenue (Millions USD) and Growth Rate (2022-2027)
9.2. Rare Biomarkers Specimen Collection And Stabilization Market Forecast by Regions (2022-2027)
9.2.1. North America Rare Biomarkers Specimen Collection And Stabilization Market Forecast (2022-2027)
9.2.1.1. United States Rare Biomarkers Specimen Collection And Stabilization Market Forecast (2022-2027)
9.2.1.2. Canada Rare Biomarkers Specimen Collection And Stabilization Market Forecast (2022-2027)
9.2.1.3. Mexico Rare Biomarkers Specimen Collection And Stabilization Market Forecast (2022-2027)
9.2.2. Europe Rare Biomarkers Specimen Collection And Stabilization Market Forecast (2022-2027)
9.2.2.1. Germany Rare Biomarkers Specimen Collection And Stabilization Market Forecast (2022-2027)
9.2.2.2. France Rare Biomarkers Specimen Collection And Stabilization Market Forecast (2022-2027)
9.2.2.3. UK Rare Biomarkers Specimen Collection And Stabilization Market Forecast (2022-2027)
9.2.2.4. Russia Rare Biomarkers Specimen Collection And Stabilization Market Forecast (2022-2027)
9.2.2.5. Italy Rare Biomarkers Specimen Collection And Stabilization Market Forecast (2022-2027)
9.2.2.6. Rest of Europe Rare Biomarkers Specimen Collection And Stabilization Market Forecast (2022-2027)
9.2.3. Asia-Pacific Rare Biomarkers Specimen Collection And Stabilization Market Forecast (2022-2027)
9.2.3.1. China Rare Biomarkers Specimen Collection And Stabilization Market Forecast (2022-2027)
9.2.3.2. Japan Rare Biomarkers Specimen Collection And Stabilization Market Forecast (2022-2027)
9.2.3.3. Korea Rare Biomarkers Specimen Collection And Stabilization Market Forecast (2022-2027)
9.2.3.4. India Rare Biomarkers Specimen Collection And Stabilization Market Forecast (2022-2027)
9.2.3.5. Southeast Asia Rare Biomarkers Specimen Collection And Stabilization Market Forecast (2022-2027)
9.2.3.6. Rest of Asia-Pacific Rare Biomarkers Specimen Collection And Stabilization Market Forecast (2022-2027)
9.2.4. South America Rare Biomarkers Specimen Collection And Stabilization Market Forecast (2022-2027)
9.2.4.1. Brazil Rare Biomarkers Specimen Collection And Stabilization Market Forecast (2022-2027)
9.2.4.2. Argentina Rare Biomarkers Specimen Collection And Stabilization Market Forecast (2022-2027)
9.2.4.3. Columbia Rare Biomarkers Specimen Collection And Stabilization Market Forecast (2022-2027)
9.2.4.4. Rest of South America Rare Biomarkers Specimen Collection And Stabilization Market Forecast (2022-2027)
9.2.5. Middle East and Africa Rare Biomarkers Specimen Collection And Stabilization Market Forecast (2022-2027)
9.2.5.1. Saudi Arabia Rare Biomarkers Specimen Collection And Stabilization Market Forecast (2022-2027)
9.2.5.2. United Arab Emirates Rare Biomarkers Specimen Collection And Stabilization Market Forecast (2022-2027)
9.2.5.3. Egypt Rare Biomarkers Specimen Collection And Stabilization Market Forecast (2022-2027)
9.2.5.4. Nigeria Rare Biomarkers Specimen Collection And Stabilization Market Forecast (2022-2027)
9.2.5.5. South Africa Rare Biomarkers Specimen Collection And Stabilization Market Forecast (2022-2027)
9.2.5.6. Turkey Rare Biomarkers Specimen Collection And Stabilization Market Forecast (2022-2027)
9.2.5.7. Rest of Middle East and Africa Rare Biomarkers Specimen Collection And Stabilization Market Forecast (2022-2027)
9.3. Rare Biomarkers Specimen Collection And Stabilization Market Forecast by Type (2022-2027)
9.3.1. Rare Biomarkers Specimen Collection And Stabilization Forecast by Type (2022-2027)
9.3.2. Rare Biomarkers Specimen Collection And Stabilization Market Share Forecast by Type (2022-2027)
9.4. Rare Biomarkers Specimen Collection And Stabilization Market Forecast by Applications (2022-2027)
9.4.1. Rare Biomarkers Specimen Collection And Stabilization Forecast by Applications (2022-2027)
9.4.2. Rare Biomarkers Specimen Collection And Stabilization Market Share Forecast by Applications (2022-2027)
List of Tables
List of Tables and Figures:
Figure United States Rare Biomarkers Specimen Collection And Stabilization Revenue (Million USD) and Growth Rate (2017-2027)
Figure Canada Rare Biomarkers Specimen Collection And Stabilization Revenue (Million USD) and Growth Rate (2017-2027)
Figure Mexico Rare Biomarkers Specimen Collection And Stabilization Revenue (Million USD) and Growth Rate (2017-2027)
Figure Germany Rare Biomarkers Specimen Collection And Stabilization Revenue (Million USD) and Growth Rate (2017-2027)
Figure France Rare Biomarkers Specimen Collection And Stabilization Revenue (Million USD) and Growth Rate (2017-2027)
Figure UK Rare Biomarkers Specimen Collection And Stabilization Revenue (Million USD) and Growth Rate (2017-2027)
Figure Russia Rare Biomarkers Specimen Collection And Stabilization Revenue (Million USD) and Growth Rate (2017-2027)
Figure Italy Rare Biomarkers Specimen Collection And Stabilization Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Europe Rare Biomarkers Specimen Collection And Stabilization Revenue (Million USD) and Growth Rate (2017-2027)
Figure China Rare Biomarkers Specimen Collection And Stabilization Revenue (Million USD) and Growth Rate (2017-2027)
Figure Japan Rare Biomarkers Specimen Collection And Stabilization Revenue (Million USD) and Growth Rate (2017-2027)
Figure Korea Rare Biomarkers Specimen Collection And Stabilization Revenue (Million USD) and Growth Rate (2017-2027)
Figure India Rare Biomarkers Specimen Collection And Stabilization Revenue (Million USD) and Growth Rate (2017-2027)
Figure Southeast Asia Rare Biomarkers Specimen Collection And Stabilization Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Asia-Pacific Rare Biomarkers Specimen Collection And Stabilization Revenue (Million USD) and Growth Rate (2017-2027)
Figure Brazil Rare Biomarkers Specimen Collection And Stabilization Revenue (Million USD) and Growth Rate (2017-2027)
Figure Argentina Rare Biomarkers Specimen Collection And Stabilization Revenue (Million USD) and Growth Rate (2017-2027)
Figure Columbia Rare Biomarkers Specimen Collection And Stabilization Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of South America Rare Biomarkers Specimen Collection And Stabilization Revenue (Million USD) and Growth Rate (2017-2027)
Figure Saudi Arabia Rare Biomarkers Specimen Collection And Stabilization Revenue (Million USD) and Growth Rate (2017-2027)
Figure United Arab Emirates Rare Biomarkers Specimen Collection And Stabilization Revenue (Million USD) and Growth Rate (2017-2027)
Figure Egypt Rare Biomarkers Specimen Collection And Stabilization Revenue (Million USD) and Growth Rate (2017-2027)
Figure Nigeria Rare Biomarkers Specimen Collection And Stabilization Revenue (Million USD) and Growth Rate (2017-2027)
Figure South Africa Rare Biomarkers Specimen Collection And Stabilization Revenue (Million USD) and Growth Rate (2017-2027)
Figure Turkey Rare Biomarkers Specimen Collection And Stabilization Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Middle East and Africa Rare Biomarkers Specimen Collection And Stabilization Revenue (Million USD) and Growth Rate (2017-2027)
Table Global Rare Biomarkers Specimen Collection And Stabilization Revenue and Revenue Share by Type (2017-2019)
Figure Global Circulating Cell Free DNA (ccfDNA) Revenue and Growth Rate (2017-2019)
Figure Global Circulating Tumor Cells (CTCs) Revenue and Growth Rate (2017-2019)
Figure Global Exosomes/Extracellular Vesicles Revenue and Growth Rate (2017-2019)
Figure Global Circulating Cell Free RNA (ccfRNA) / miRNA Revenue and Growth Rate (2017-2019)
Table Global Rare Biomarkers Specimen Collection And Stabilization Revenue and Revenue Share by Applications (2017-2019)
Figure Global Research Revenue and Growth Rate (2017-2019)
Figure Global Diagnostics Revenue and Growth Rate (2017-2019)
Table Global Rare Biomarkers Specimen Collection And Stabilization Revenue by Regions (2017-2019)
Figure North America Rare Biomarkers Specimen Collection And Stabilization Growth Rate (2017-2019)
Figure North America Rare Biomarkers Specimen Collection And Stabilization Revenue and Growth Rate (2017-2019)
Figure North America Rare Biomarkers Specimen Collection And Stabilization by Countries (2017-2019)
Figure North America Rare Biomarkers Specimen Collection And Stabilization Revenue (Million USD) by Countries (2017-2019)
Figure United States Rare Biomarkers Specimen Collection And Stabilization Growth Rate (2017-2019)
Figure United States Rare Biomarkers Specimen Collection And Stabilization Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Canada Rare Biomarkers Specimen Collection And Stabilization Growth Rate (2017-2019)
Figure Canada Rare Biomarkers Specimen Collection And Stabilization Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Mexico Rare Biomarkers Specimen Collection And Stabilization Growth Rate (2017-2019)
Figure Mexico Rare Biomarkers Specimen Collection And Stabilization Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Europe Rare Biomarkers Specimen Collection And Stabilization Growth Rate (2017-2019)
Figure Europe Rare Biomarkers Specimen Collection And Stabilization Revenue and Growth Rate (2017-2019)
Figure Europe Rare Biomarkers Specimen Collection And Stabilization by Countries (2017-2019)
Figure Europe Rare Biomarkers Specimen Collection And Stabilization Revenue (Million USD) by Countries (2017-2019)
Figure Germany Rare Biomarkers Specimen Collection And Stabilization Growth Rate (2017-2019)
Figure Germany Rare Biomarkers Specimen Collection And Stabilization Revenue (Millions USD) and Growth Rate (2017-2019)
Figure France Rare Biomarkers Specimen Collection And Stabilization Growth Rate (2017-2019)
Figure France Rare Biomarkers Specimen Collection And Stabilization Revenue (Millions USD) and Growth Rate (2017-2019)
Figure UK Rare Biomarkers Specimen Collection And Stabilization Growth Rate (2017-2019)
Figure UK Rare Biomarkers Specimen Collection And Stabilization Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Russia Rare Biomarkers Specimen Collection And Stabilization Growth Rate (2017-2019)
Figure Russia Rare Biomarkers Specimen Collection And Stabilization Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Italy Rare Biomarkers Specimen Collection And Stabilization Growth Rate (2017-2019)
Figure Italy Rare Biomarkers Specimen Collection And Stabilization Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of Europe Rare Biomarkers Specimen Collection And Stabilization Growth Rate (2017-2019)
Figure Rest of Europe Rare Biomarkers Specimen Collection And Stabilization Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Asia-Pacific Rare Biomarkers Specimen Collection And Stabilization Growth Rate (2017-2019)
Figure Asia-Pacific Rare Biomarkers Specimen Collection And Stabilization Revenue and Growth Rate (2017-2019)
Figure Asia-Pacific Rare Biomarkers Specimen Collection And Stabilization by Countries (2017-2019)
Figure Asia-Pacific Rare Biomarkers Specimen Collection And Stabilization Revenue (Million USD) by Countries (2017-2019)
Figure China Rare Biomarkers Specimen Collection And Stabilization Growth Rate (2017-2019)
Figure China Rare Biomarkers Specimen Collection And Stabilization Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Japan Rare Biomarkers Specimen Collection And Stabilization Growth Rate (2017-2019)
Figure Japan Rare Biomarkers Specimen Collection And Stabilization Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Korea Rare Biomarkers Specimen Collection And Stabilization Growth Rate (2017-2019)
Figure Korea Rare Biomarkers Specimen Collection And Stabilization Revenue (Millions USD) and Growth Rate (2017-2019)
Figure India Rare Biomarkers Specimen Collection And Stabilization Growth Rate (2017-2019)
Figure India Rare Biomarkers Specimen Collection And Stabilization Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Southeast Asia Rare Biomarkers Specimen Collection And Stabilization Growth Rate (2017-2019)
Figure Southeast Asia Rare Biomarkers Specimen Collection And Stabilization Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of Asia-Pacific Rare Biomarkers Specimen Collection And Stabilization Growth Rate (2017-2019)
Figure Rest of Asia-Pacific Rare Biomarkers Specimen Collection And Stabilization Revenue (Millions USD) and Growth Rate (2017-2019)
Figure South America Rare Biomarkers Specimen Collection And Stabilization Growth Rate (2017-2019)
Figure South America Rare Biomarkers Specimen Collection And Stabilization Revenue and Growth Rate (2017-2019)
Figure South America Rare Biomarkers Specimen Collection And Stabilization by Countries (2017-2019)
Figure South America Rare Biomarkers Specimen Collection And Stabilization Revenue (Million USD) by Countries (2017-2019)
Figure Brazil Rare Biomarkers Specimen Collection And Stabilization Growth Rate (2017-2019)
Figure Brazil Rare Biomarkers Specimen Collection And Stabilization Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Argentina Rare Biomarkers Specimen Collection And Stabilization Growth Rate (2017-2019)
Figure Argentina Rare Biomarkers Specimen Collection And Stabilization Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Columbia Rare Biomarkers Specimen Collection And Stabilization Growth Rate (2017-2019)
Figure Columbia Rare Biomarkers Specimen Collection And Stabilization Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of South America Rare Biomarkers Specimen Collection And Stabilization Growth Rate (2017-2019)
Figure Rest of South America Rare Biomarkers Specimen Collection And Stabilization Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Middle East and Africa Rare Biomarkers Specimen Collection And Stabilization Growth Rate (2017-2019)
Figure Middle East and Africa Rare Biomarkers Specimen Collection And Stabilization Revenue and Growth Rate (2017-2019)
Figure Middle East and Africa Rare Biomarkers Specimen Collection And Stabilization by Countries (2017-2019)
Figure Middle East and Africa Rare Biomarkers Specimen Collection And Stabilization Revenue (Million USD) by Countries (2017-2019)
Figure Saudi Arabia Rare Biomarkers Specimen Collection And Stabilization Growth Rate (2017-2019)
Figure Saudi Arabia Rare Biomarkers Specimen Collection And Stabilization Revenue (Millions USD) and Growth Rate (2017-2019)
Figure United Arab Emirates Rare Biomarkers Specimen Collection And Stabilization Growth Rate (2017-2019)
Figure United Arab Emirates Rare Biomarkers Specimen Collection And Stabilization Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Egypt Rare Biomarkers Specimen Collection And Stabilization Growth Rate (2017-2019)
Figure Egypt Rare Biomarkers Specimen Collection And Stabilization Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Nigeria Rare Biomarkers Specimen Collection And Stabilization Growth Rate (2017-2019)
Figure Nigeria Rare Biomarkers Specimen Collection And Stabilization Revenue (Millions USD) and Growth Rate (2017-2019)
Figure South Africa Rare Biomarkers Specimen Collection And Stabilization Growth Rate (2017-2019)
Figure South Africa Rare Biomarkers Specimen Collection And Stabilization Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Turkey Rare Biomarkers Specimen Collection And Stabilization Growth Rate (2017-2019)
Figure Turkey Rare Biomarkers Specimen Collection And Stabilization Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of Middle East and Africa Rare Biomarkers Specimen Collection And Stabilization Growth Rate (2017-2019)
Figure Rest of Middle East and Africa Rare Biomarkers Specimen Collection And Stabilization Revenue (Millions USD) and Growth Rate (2017-2019)
Table Agena Bioscience Rare Biomarkers Specimen Collection And Stabilization Financial Overview
Table ANGLE plc Rare Biomarkers Specimen Collection And Stabilization Financial Overview
Table AS ONE INTERNATIONAL Rare Biomarkers Specimen Collection And Stabilization Financial Overview
Table BioChain Institute, Inc. Rare Biomarkers Specimen Collection And Stabilization Financial Overview
Table Biolidics Limited Rare Biomarkers Specimen Collection And Stabilization Financial Overview
Table Biomatrica Rare Biomarkers Specimen Collection And Stabilization Financial Overview
Table Bio-Techne Corporation Rare Biomarkers Specimen Collection And Stabilization Financial Overview
Table BioVision, Inc. Rare Biomarkers Specimen Collection And Stabilization Financial Overview
Table Caltag Medsystems Limited Rare Biomarkers Specimen Collection And Stabilization Financial Overview
Table OraSure Technologies Inc. Rare Biomarkers Specimen Collection And Stabilization Financial Overview
Figure Global Rare Biomarkers Specimen Collection And Stabilization Revenue (Millions USD) and Growth Rate (2019-2027)
Table Rare Biomarkers Specimen Collection And Stabilization Market Forecast by Regions (2019-2027)
Figure North America Rare Biomarkers Specimen Collection And Stabilization Market Forecast (2019-2027)
Figure United States Rare Biomarkers Specimen Collection And Stabilization Market Forecast (2019-2027)
Figure Canada Rare Biomarkers Specimen Collection And Stabilization Market Forecast (2019-2027)
Figure Mexico Rare Biomarkers Specimen Collection And Stabilization Market Forecast (2019-2027)
Figure Europe Rare Biomarkers Specimen Collection And Stabilization Market Forecast (2019-2027)
Figure Germany Rare Biomarkers Specimen Collection And Stabilization Market Forecast (2019-2027)
Figure France Rare Biomarkers Specimen Collection And Stabilization Market Forecast (2019-2027)
Figure UK Rare Biomarkers Specimen Collection And Stabilization Market Forecast (2019-2027)
Figure Russia Rare Biomarkers Specimen Collection And Stabilization Market Forecast (2019-2027)
Figure Italy Rare Biomarkers Specimen Collection And Stabilization Market Forecast (2019-2027)
Figure Rest of Europe Rare Biomarkers Specimen Collection And Stabilization Market Forecast (2019-2027)
Figure Asia-Pacific Rare Biomarkers Specimen Collection And Stabilization Market Forecast (2019-2027)
Figure China Rare Biomarkers Specimen Collection And Stabilization Market Forecast (2019-2027)
Figure Japan Rare Biomarkers Specimen Collection And Stabilization Market Forecast (2019-2027)
Figure Korea Rare Biomarkers Specimen Collection And Stabilization Market Forecast (2019-2027)
Figure India Rare Biomarkers Specimen Collection And Stabilization Market Forecast (2019-2027)
Figure Southeast Asia Rare Biomarkers Specimen Collection And Stabilization Market Forecast (2019-2027)
Figure Rest of Asia-Pacific Rare Biomarkers Specimen Collection And Stabilization Market Forecast (2019-2027)
Figure South America Rare Biomarkers Specimen Collection And Stabilization Market Forecast (2019-2027)
Figure Brazil Rare Biomarkers Specimen Collection And Stabilization Market Forecast (2019-2027)
Figure Argentina Rare Biomarkers Specimen Collection And Stabilization Market Forecast (2019-2027)
Figure Columbia Rare Biomarkers Specimen Collection And Stabilization Market Forecast (2019-2027)
Figure Rest of South America Rare Biomarkers Specimen Collection And Stabilization Market Forecast (2019-2027)
Figure Middle East and Africa Rare Biomarkers Specimen Collection And Stabilization Market Forecast (2019-2027)
Figure Saudi Arabia Rare Biomarkers Specimen Collection And Stabilization Market Forecast (2019-2027)
Figure United Arab Emirates Rare Biomarkers Specimen Collection And Stabilization Market Forecast (2019-2027)
Figure Egypt Rare Biomarkers Specimen Collection And Stabilization Market Forecast (2019-2027)
Figure Nigeria Rare Biomarkers Specimen Collection And Stabilization Market Forecast (2019-2027)
Figure South Africa Rare Biomarkers Specimen Collection And Stabilization Market Forecast (2019-2027)
Figure Turkey Rare Biomarkers Specimen Collection And Stabilization Market Forecast (2019-2027)
Figure Rest of Middle East and Africa Rare Biomarkers Specimen Collection And Stabilization Market Forecast (2019-2027)
Figure Global Rare Biomarkers Specimen Collection And Stabilization Forecast by Type (2019-2027)
Figure Global Rare Biomarkers Specimen Collection And Stabilization Market Share Forecast by Type (2019-2027)
Figure Global Rare Biomarkers Specimen Collection And Stabilization Forecast by Type (2019-2027)
Figure Global Rare Biomarkers Specimen Collection And Stabilization Forecast by Applications (2019-2027)
Figure Global Rare Biomarkers Specimen Collection And Stabilization Market Share Forecast by Applications (2019-2027)
Figure Global Rare Biomarkers Specimen Collection And Stabilization Forecast by Applications (2019-2027)
Please Note: Data related to the Companies are subject to Availability.
Research Methodology
We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.
Data Mining
Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.
Data Collection Matrix
|
Data Collection Matrix |
Supply Side |
Demand Side |
|
Primary Data Sources |
|
|
|
Secondary Data Sources |
|
|
Market Modeling and Forecasting
We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.
- Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
- Number of patients for particular device or medical procedure and
- Repeated use of particular device depending on health and condition of patient
- Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.
We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.
Data Validation
We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.
Data Triangulation
Industry Analysis
|
Qualitative Data |
Quantitative Data (2017-2025) |
|
|